US2020376278A1PendingUtilityA1
Waveform shapes for treating neurological disorders optimized for energy efficiency
Est. expiryMay 27, 2030(~3.8 yrs left)· nominal 20-yr term from priority
A61N 1/36175A61N 1/3606A61N 1/0529A61N 1/36146
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Systems and methods for stimulation of neurological tissue apply a stimulation waveform that is derived by a developed genetic algorithm (GA), which may be coupled to a computational model of extracellular stimulation of a mammalian myelinated axon. The waveform is optimized for energy efficiency.
Claims
exact text as granted — not AI-modifiedHaving thus described the invention, we claim:
1 . A stimulation waveform for application to targeted neurological tissue, the waveform being selected from a set of waveforms consisting essentially of Gaussian curves having varying pulse widths and derived by a prescribed genetic algorithm (GA) coupled to a computational model of extracellular stimulation of a mammalian myelinated axon, wherein the set of stimulus waveforms are optimized for energy efficiency.
2 . The waveform according to claim 1 wherein the waveform is monophasic.
3 . The waveform according to claim 1 wherein the waveform is biphasic.
4 . A system for creating a stimulation waveform optimized for energy efficiency comprising:
a population of parent stimulation waveforms; a genetic algorithm (GA) for generating a population of offspring stimulation waveforms by mating the population of parent stimulation waveforms, a computational model of extracellular stimulation of a mammalian myelinated axon, being operative for assessing the fitness of individual offspring stimulation waveforms generated by the genetic algorithm in terms of energy efficiency and selecting as a new population of the parent stimulation waveforms the current offspring stimulation waveforms having the highest energy efficiency values, the selection terminating when predetermined termination criteria is met.
5 . A system for neurological tissue stimulation comprising:
a lead sized and configured for implantation in a targeted tissue stimulation region with a brain of a patient, and a pulse generator coupled to the lead, the pulse generator including a power source comprising a battery and a microprocessor coupled to the battery and being operable to apply to the lead a stimulation waveform derived through use of a global optimization algorithm.Join the waitlist — get patent alerts
Track US2020376278A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.